The role of TH17 cells in multiple sclerosis: Therapeutic implications
Tobias Moser, Katja Akgün, Undine Proschmann, Johann Sellner, Tjalf Ziemssen
Topics & Concepts
NatalizumabMultiple sclerosisImmunologyFingolimodInterleukin 17MedicineAlemtuzumabPathogenesisCD52Interleukin 23Immune systemBiologyAntibodyMultiple Sclerosis Research StudiesT-cell and B-cell ImmunologyImmunotherapy and Immune Responses